Motexafin gadolinium

Motexafin gadolinium (pronunciation: moe-TEX-a-fin gad-oh-LIN-ee-um) is a pharmaceutical drug used in the treatment of cancer. It is a member of the class of drugs known as radiosensitizers, which are used to make cancer cells more susceptible to radiation therapy.

Etymology

The name "Motexafin gadolinium" is derived from the chemical components of the drug. "Motexafin" is a proprietary name, and "gadolinium" refers to the gadolinium ion, a rare earth metal used in various medical and industrial applications.

Usage

Motexafin gadolinium is used in conjunction with radiation therapy to treat certain types of cancer, including brain tumors and lung cancer. It works by increasing the sensitivity of cancer cells to radiation, thereby enhancing the effectiveness of the treatment.

Related Terms

• Radiosensitizer
• Radiation therapy
• Gadolinium
• Pharmaceutical drug
• Cancer
• Brain tumor
• Lung cancer

See Also

• Chemotherapy
• Oncology
• Radiology

External links

• Medical encyclopedia article on Motexafin gadolinium
• Wikipedia's article - Motexafin gadolinium

This WikiMD article is a stub. You can help make it a full article.

---

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski